These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17244028)

  • 1. Srcasm overexpression in psoriasis-insights into pathogenesis.
    Pulitzer M; Li W; Hanson M; Singh F; Elenitsas R; Gelfand JM; VanVoorhees A; Seykora JT
    J Cutan Pathol; 2007 Feb; 34(2):160-5. PubMed ID: 17244028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Srcasm: a novel Src activating and signaling molecule.
    Seykora JT; Mei L; Dotto GP; Stein PL
    J Biol Chem; 2002 Jan; 277(4):2812-22. PubMed ID: 11711534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation.
    Li W; Marshall C; Mei L; Gelfand J; Seykora JT
    J Biol Chem; 2007 Jan; 282(2):1161-9. PubMed ID: 17046829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Srcasm modulates EGF and Src-kinase signaling in keratinocytes.
    Li W; Marshall C; Mei L; Dzubow L; Schmults C; Dans M; Seykora J
    J Biol Chem; 2005 Feb; 280(7):6036-46. PubMed ID: 15579470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.
    Zhao L; Li W; Marshall C; Griffin T; Hanson M; Hick R; Dentchev T; Williams E; Werth A; Miller C; Bashir H; Pear W; Seykora JT
    Cancer Res; 2009 Dec; 69(24):9439-47. PubMed ID: 19934324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Srcasm expression in hyperproliferative cutaneous lesions.
    Meulener MC; Ayli EE; Elenitsas R; Seykora JT
    J Cutan Pathol; 2009 Mar; 36(3):291-5. PubMed ID: 19220627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF.
    Man XY; Yang XH; Cai SQ; Bu ZY; Zheng M
    J Cell Mol Med; 2008 Apr; 12(2):649-60. PubMed ID: 18419602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HAX-1, identified by differential display reverse transcription polymerase chain reaction, is overexpressed in lesional psoriasis.
    Mirmohammadsadegh A; Tartler U; Michel G; Baer A; Walz M; Wolf R; Ruzicka T; Hengge UR
    J Invest Dermatol; 2003 Jun; 120(6):1045-51. PubMed ID: 12787133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of antiapoptotic protein c-FLIP is upregulated in psoriasis epidermis.
    Yang J; Li Y; Liu YQ; Long JW; Tian F; Dong J; Shen GX; Tu YT; Tao J
    Eur J Dermatol; 2009; 19(1):29-33. PubMed ID: 19059832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proteasome maturation protein POMP increases proteasome assembly and activity in psoriatic lesional skin.
    Zieba BA; Henry L; Lacroix M; Jemaà M; Lavabre-Bertrand T; Meunier L; Coux O; Stoebner PE
    J Dermatol Sci; 2017 Oct; 88(1):10-19. PubMed ID: 28728908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration and significance of heparin-binding epidermal-growth-factor-like growth factor in psoriatic epidermis.
    Zheng Y; Peng Z; Wang Y; Tan S; Xi Y; Wang G
    Dermatology; 2003; 207(1):22-7. PubMed ID: 12835543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOD-like receptor signaling and inflammasome-related pathways are highlighted in psoriatic epidermis.
    Tervaniemi MH; Katayama S; Skoog T; Siitonen HA; Vuola J; Nuutila K; Sormunen R; Johnsson A; Linnarsson S; Suomela S; Kankuri E; Kere J; Elomaa O
    Sci Rep; 2016 Mar; 6():22745. PubMed ID: 26976200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CXC receptor 2 is overexpressed in psoriatic epidermis.
    Kulke R; Bornscheuer E; Schlüter C; Bartels J; Röwert J; Sticherling M; Christophers E
    J Invest Dermatol; 1998 Jan; 110(1):90-4. PubMed ID: 9424095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed death-ligand 1, 2 expressions are decreased in the psoriatic epidermis.
    Kim DS; Je JH; Kim SH; Shin D; Kim TG; Kim DY; Kim SM; Lee MG
    Arch Dermatol Res; 2015 Aug; 307(6):531-8. PubMed ID: 26133691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
    Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP
    J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased Srcasm expression in esophageal squamous cell carcinoma in a Chinese population.
    Qi Y; Li X; Zhao L; Seykora JT
    Anticancer Res; 2010 Sep; 30(9):3535-9. PubMed ID: 20944134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes.
    Rivier M; Safonova I; Lebrun P; Griffiths CE; Ailhaud G; Michel S
    J Invest Dermatol; 1998 Dec; 111(6):1116-21. PubMed ID: 9856826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of SMAD2, 4 and 6 mRNA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin.
    Yu H; Mrowietz U; Seifert O
    Acta Derm Venereol; 2009; 89(4):351-6. PubMed ID: 19688145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis.
    de Jongh GJ; Zeeuwen PL; Kucharekova M; Pfundt R; van der Valk PG; Blokx W; Dogan A; Hiemstra PS; van de Kerkhof PC; Schalkwijk J
    J Invest Dermatol; 2005 Dec; 125(6):1163-73. PubMed ID: 16354186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.